| Multiple Sclerosis |
1 |
1 |
| Precision Medicine |
0 |
0.7 |
| Genetics |
0 |
0.52 |
| Genomic Medicine |
0 |
0.42 |
| Biologic Therapy |
0 |
0.21 |
| Adverse Effects |
0 |
0.17 |
| Board Certification |
0 |
0.17 |
| Disability |
0 |
0.17 |
| Disease-Modifying Therapy |
0 |
0.17 |
| Multiple Sclerosis Relapse |
0 |
0.17 |
| Multiple Sclerosis Treatment |
0 |
0.17 |
| New York |
0 |
0.17 |
| Pharmacogenomics |
0 |
0.17 |